Handelsbanken Fonder
FLNA

Handelsbanken Fonder’s Filana Therapeutics FLNA Stock Holding History

Handelsbanken Fonder’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-9,800
Closed -$240K – 1578
2023
Q2 		$240K Hold
9,800
– – ﹤0.01% 1439
2023
Q1 		$236K Buy
9,800
+500
+5% +$13.9K ﹤0.01% 1396
2022
Q4 		$275K Sell
9,300
-700
-7% -$25.2K ﹤0.01% 1294
2022
Q3 		$418K Hold
10,000
– – ﹤0.01% 1067
2022
Q2 		$281K Sell
10,000
-200
-2% -$5.05K ﹤0.01% 1363
2022
Q1 		$379K Hold
10,200
– – ﹤0.01% 1386
2021
Q4 		$446K Sell
10,200
-4,300
-30% -$225K ﹤0.01% 1427
2021
Q3 		$900K Buy
14,500
+100
+0.7% +$8.35K ﹤0.01% 962
2021
Q2 		$1.23M Buy
+14,400
New +$771K 0.01% 810

Other funds holding FLNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
GCM
Gallacher Capital Management Lone Tree, Colorado $178M AUM 29.29% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return

Handelsbanken Fonder's FLNA Position: Q3 2023 in Review

Handelsbanken Fonder sold out of Filana Therapeutics (FLNA) in Q3 2023, closing a stake of 9,800 shares — an estimated $240K sold.

Handelsbanken Fonder first reported a position in FLNA in Q2 2021 and held it in 9 quarters. The position peaked at $1.23M in Q2 2021. 140 funds tracked by Wall St. Rank hold FLNA as of Q3 2023.

  • Handelsbanken Fonder reported no remaining Filana Therapeutics position as of Q3 2023 after selling out during the quarter.
  • Handelsbanken Fonder sold 9,800 Filana Therapeutics shares in Q3 2023, an estimated $240K.
  • Handelsbanken Fonder first reported a position in Filana Therapeutics in Q2 2021 and held it in 9 quarters.
  • Handelsbanken Fonder's Filana Therapeutics position peaked at $1.23M in Q2 2021.
  • 140 funds tracked by Wall St. Rank held Filana Therapeutics as of Q3 2023.

Based on Handelsbanken Fonder's 13F filing for Q3 2023, filed 19 Oct 2023.